Abstract
Urgent Cytoreductive Chemotherapy for Newly Diagnosed Patients with AML Is Safe and Feasible and Facilitates Enrollment on Investigational Clinical Trials
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have